BiondVax Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BVXV and other ETFs, options, and stocks.

About BVXV

BiondVax Pharmaceuticals Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza. 

CEO
Amir Reichman
CEOAmir Reichman
Employees
15
Employees15
Headquarters
Jerusalem, Jerusalem
HeadquartersJerusalem, Jerusalem
Founded
2003
Founded2003
Employees
15
Employees15

BVXV Key Statistics

Market cap
18.72M
Market cap18.72M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
15.19K
Average volume15.19K
High today
$9.89
High today$9.89
Low today
$9.68
Low today$9.68
Open price
$9.68
Open price$9.68
Volume
4.52K
Volume4.52K
52 Week high
$34.90
52 Week high$34.90
52 Week low
$5.34
52 Week low$5.34

BVXV News

Yahoo Finance 11h
IBN (InvestorBrandNetwork) Coverage Initiated for BiondVax Pharmaceuticals Ltd. - Yahoo Finance

BiondVax Pharmaceuticals Ltd. LOS ANGELES, Dec. 06, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), a biopharmaceutic...

IBN (InvestorBrandNetwork) Coverage Initiated for BiondVax Pharmaceuticals Ltd. - Yahoo Finance
Yahoo Finance 12h
Professor Dr. Matthias Dobbelstein joins BiondVax’s Scientific Advisory Board - Yahoo Finance

BiondVax Pharmaceuticals Ltd. Professor Dr. med. Matthias Dobbelstein Professor Dr. med. Matthias Dobbelstein Jerusalem, Dec. 06, 2022 (GLOBE NEWSWIRE) -- vi...

Professor Dr. Matthias Dobbelstein joins BiondVax’s Scientific Advisory Board - Yahoo Finance
Yahoo Finance 6d
BiondVax announces Third Quarter 2022 Financial Results and Provides Business Update - Yahoo Finance

BiondVax Pharmaceuticals Ltd. JERUSALEM, Nov. 30, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), which focuses on de...

BiondVax announces Third Quarter 2022 Financial Results and Provides Business Update - Yahoo Finance

BVXV Earnings

-$0.20
-$0.11
-$0.03
$0.06
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
-$0.10 per share
Estimated-$0.10 per share
Actual
$0.06 per share
Actual$0.06 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.